BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ala M. Target c-Myc to treat pancreatic cancer. Cancer Biol Ther 2022;:1-17. [PMID: 34978469 DOI: 10.1080/15384047.2021.2017223] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu S, Qin Z, Mao Y, Zhang W, Wang Y, Jia L, Peng X. Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma. OncoImmunology 2022;11:2130583. [DOI: 10.1080/2162402x.2022.2130583] [Reference Citation Analysis]
2 Dutta M, Mohapatra D, Mohapatra AP, Senapati S, Roychowdhury A. ATAD2 suppression enhances the combinatorial effect of gemcitabine and radiation in pancreatic cancer cells. Biochemical and Biophysical Research Communications 2022;635:179-186. [DOI: 10.1016/j.bbrc.2022.10.021] [Reference Citation Analysis]
3 Sequera C, Grattarola M, Holczbauer A, Dono R, Pizzimenti S, Barrera G, Wangensteen KJ, Maina F. MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities. Cell Death Dis 2022;13:994. [DOI: 10.1038/s41419-022-05411-6] [Reference Citation Analysis]
4 Zhang W, Li S, Li C, Li T, Huang Y. Remodeling tumor microenvironment with natural products to overcome drug resistance. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1051998] [Reference Citation Analysis]
5 Romeo MA, Gilardini Montani MS, Arena A, Benedetti R, D'Orazi G, Cirone M. c-Myc Sustains Pancreatic Cancer Cell Survival and mutp53 Stability through the Mevalonate Pathway. Biomedicines 2022;10:2489. [PMID: 36289751 DOI: 10.3390/biomedicines10102489] [Reference Citation Analysis]
6 Liu Y, Vandekeere A, Xu M, Altea-manzano P, Fendt S. Metabolite-derived protein modifications modulating oncogenic signaling. Front Oncol 2022;12:988626. [DOI: 10.3389/fonc.2022.988626] [Reference Citation Analysis]
7 Marconi GD, Della Rocca Y, Fonticoli L, Melfi F, Rajan TS, Carradori S, Pizzicannella J, Trubiani O, Diomede F. C-Myc Expression in Oral Squamous Cell Carcinoma: Molecular Mechanisms in Cell Survival and Cancer Progression. Pharmaceuticals 2022;15:890. [DOI: 10.3390/ph15070890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hung YH, Chen LT, Hung WC. The Trinity: Interplay among Cancer Cells, Fibroblasts, and Immune Cells in Pancreatic Cancer and Implication of CD8+ T Cell-Orientated Therapy. Biomedicines 2022;10:926. [PMID: 35453676 DOI: 10.3390/biomedicines10040926] [Reference Citation Analysis]